Click here to get in touch with the Profounda Team.
Toll Free: (407) 270-7790
Orphan drug status approval for Acanthamoeba Keratitis received by Profounda for Miltefosine
PR Newswire
Dec 31, 2016
1 min read
Orphan indication received by Profounda is for the treatment of Acanthamoeba Keratitis, also commonly known as AK usually associated with contact lens wear.
Comments